Off-pump coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for coronary artery revascularization
Nan Li, Xin Xiong, Kun Yang, Yijun Xu, Zhiqiang Chen, Peng Liu, Wen Wen, Xiaowei Li, Jin Dong, Shoudong Wei, Durong Chen, Xiaolong Zhang, Dajiang Yuan, Yongzhi Deng · 2024
Read Off-pump coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for coronary artery revascularization by Nan Li, Xin Xiong, Kun Yang, Yijun Xu, Zhiqiang Chen, Peng Liu, Wen Wen, Xiaowei Li, Jin Dong, Shoudong Wei, Durong Chen, Xiaolong Zhang, Dajiang Yuan, Yongzhi Deng (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11672580.txt.
Description
Nan Li and co-authors compare bypass surgery against stenting for the toughest coronary disease in a 2024 study. Patients with left main or triple-vessel disease can get off-pump bypass grafts or modern drug-eluting stents. Records from one Chinese heart hospital over eight years supplied the contest.
After matching, three hundred sixteen pairs were compared over about four years. Deaths, major events, and heart attacks did not differ between groups. Stent patients more often needed repeat procedures and saw chest pain return. Bypass patients, though, suffered more strokes. The authors read bypass as a favorable strategy for this disease pattern, with the stroke trade-off kept in view.
Catalog record
| CREATOR | Nan Li, Xin Xiong, Kun Yang, Yijun Xu, Zhiqiang Chen, Peng Liu, Wen Wen, Xiaowei Li, Jin Dong, Shoudong Wei, Durong Chen, Xiaolong Zhang, Dajiang Yuan, Yongzhi Deng |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |